Balyasny Asset Management L.P.
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1218710
Chicago, IL
Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,391,066
+$5,018,164 QoQ
Shares Held
1,107,271
+28.9% QoQ
Ownership
0.996%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Derivatives in AMLX
reported options exposure · as of Jun 30, 2023CallValue
$9,167,250
CallShares
425,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $180,059,722 across 19 Drug Manufacturers - Specialty & Generic names. AMLX ranks #6 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
539,382 | $40,912,124 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
499,792 | $24,064,984 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
1,327,545 | $23,218,762 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
36,623 | $21,716,706 | |
| 5 | ALKS |
Alkermes plc.
|
586,775 | $20,748,363 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
1,107,271 | $15,391,066 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
2,900,570 | $12,037,365 | |
| 8 | PRGO |
PERRIGO Co plc
|
804,856 | $8,644,153 |
All Filings in AMLX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,391,066 | 1,107,271 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,372,902 | 858,684 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,062,944 | 1,476,302 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $525,898 | 148,559 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $189,937 | 50,248 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $164,925 | 50,903 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $43,485 | 22,887 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $289,954 | 19,698 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $12,759,890 | 696,881 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $25,320,009 | 1,173,853 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $9,167,250 | 425,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $12,347,474 | 420,841 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $23,853,183 | 645,553 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,386,052 | 191,334 | Shares | Sole | 2022-11-15 | |
| 2022-03-31 | $808,457 | 62,915 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||